JPS4633956Y1
(pl)
|
1967-06-09 |
1971-11-24 |
|
|
JPS5959330U
(ja)
|
1982-10-13 |
1984-04-18 |
斉藤 晃正 |
通気性防水部材
|
JPS614960A
(ja)
|
1984-06-19 |
1986-01-10 |
Fuji Photo Film Co Ltd |
分析試薬および多層化学分析要素
|
CA2061159A1
(en)
|
1991-02-26 |
1992-08-27 |
Michael A. Poss |
Imidazole and benzimidazole derivatives
|
JPH04346987A
(ja)
*
|
1991-05-23 |
1992-12-02 |
Nippon Soda Co Ltd |
イミダゾピラジン誘導体及びその電子写真感光体としての利用
|
DE4129603A1
(de)
|
1991-09-06 |
1993-03-11 |
Thomae Gmbh Dr K |
Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
US5234923A
(en)
|
1991-12-16 |
1993-08-10 |
E. R. Squibb & Sons, Inc. |
Substitute indole and benzimidazole derivatives
|
EP0630241A1
(en)
|
1992-03-20 |
1994-12-28 |
The Wellcome Foundation Limited |
Indole derivatives with antiviral activity
|
JP3383820B2
(ja)
*
|
1993-06-02 |
2003-03-10 |
独立行政法人産業技術総合研究所 |
有機非線形光学材料
|
DE4330959A1
(de)
|
1993-09-09 |
1995-03-16 |
Schering Ag |
Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
|
DE4338770A1
(de)
|
1993-11-12 |
1995-05-18 |
Matthias Dr Lehr |
Indol-2-alkansäuren und ihre Derivate als Hemmstoffe der Phospholipase A¶2¶
|
US5482960A
(en)
|
1994-11-14 |
1996-01-09 |
Warner-Lambert Company |
Nonpeptide endothelin antagonists
|
JPH08157461A
(ja)
|
1994-12-07 |
1996-06-18 |
Sankyo Co Ltd |
スルホン誘導体
|
BR9609353A
(pt)
|
1995-06-07 |
1999-05-11 |
Sugen Inc |
Composição farmacêutica conveniente para administração em humanos processo para melhorar sintomas de uma desordem proliferativa celular e compostos
|
US6630496B1
(en)
|
1996-08-26 |
2003-10-07 |
Genetics Institute Llc |
Inhibitors of phospholipase enzymes
|
US5751787A
(en)
|
1996-09-05 |
1998-05-12 |
Nanoptics, Inc. |
Materials and methods for improved radiography
|
DK0948495T3
(da)
|
1996-11-19 |
2004-06-01 |
Amgen Inc |
Aryl- og heteroarylsubstitueret, kondenseret pyrrol som antiinflammatoriske midler
|
WO1998039342A1
(en)
|
1997-03-07 |
1998-09-11 |
Metabasis Therapeutics, Inc. |
Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase
|
EP0986557A4
(en)
|
1997-06-05 |
2001-03-14 |
Merck & Co Inc |
GONADOLIBERIN ANTAGONISTS
|
JP2001520996A
(ja)
|
1997-10-28 |
2001-11-06 |
メルク エンド カムパニー インコーポレーテッド |
性腺刺激ホルモン放出ホルモン拮抗薬
|
IL137719A0
(en)
|
1998-02-25 |
2001-10-31 |
Genetics Inst |
Inhibitors of phospholipase enzymes
|
AU2782699A
(en)
|
1998-02-25 |
1999-09-15 |
Genetics Institute, Llc |
Inhibitors of phospholipase enzymes
|
IL137540A0
(en)
|
1998-02-25 |
2001-07-24 |
Genetics Inst |
Inhibitors of phospholipase a2
|
WO1999051225A1
(en)
|
1998-04-02 |
1999-10-14 |
Merck & Co., Inc. |
Antidiabetic agents
|
US6534503B1
(en)
|
1998-04-28 |
2003-03-18 |
Lion Bioscience Ag |
Melanocortin receptor-3 ligands to treat sexual dysfunction
|
AU4981199A
(en)
|
1998-07-08 |
2000-02-01 |
Gregory N. Beatch |
Compositions and methods for modulating sexual activity
|
AU1738900A
(en)
|
1998-11-19 |
2000-06-05 |
Nortran Pharmaceuticals Inc. |
Serotonin ligands as pro-erectile compounds
|
JP4221129B2
(ja)
|
1999-02-15 |
2009-02-12 |
富士フイルム株式会社 |
含窒素ヘテロ環化合物、有機発光素子材料、有機発光素子
|
WO2001021634A1
(en)
|
1999-09-21 |
2001-03-29 |
Lion Bioscience Ag |
Benzimidazole derivatives and combinatorial libraries thereof
|
CA2387351C
(en)
|
1999-10-19 |
2009-09-08 |
Merck & Co., Inc. |
Indole derivatives as tyrosine kinase inhibitors
|
AU778042B2
(en)
|
1999-10-19 |
2004-11-11 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
WO2001030778A1
(en)
|
1999-10-27 |
2001-05-03 |
Novartis Ag |
Thiazole and imidazo [4,5-b] pyridine compounds and their pharmaceutical use
|
WO2001047935A2
(en)
|
1999-12-22 |
2001-07-05 |
Metabasis Therapeutics, Inc. |
Novel bisamidate phosphonate prodrugs
|
US20030187261A1
(en)
|
2000-01-07 |
2003-10-02 |
Libor Havlicek |
Purine derivatives, process for their preparation and use thereof
|
NZ519326A
(en)
|
2000-01-14 |
2005-02-25 |
Schering Ag |
1,2-diarylbenzimidazoles for treating diseases that are associated with a microglia activation
|
CA2402516A1
(en)
|
2000-03-20 |
2001-09-27 |
Roopa Rai |
Non-amidine containing protease inhibitors
|
CN1450896A
(zh)
|
2000-07-28 |
2003-10-22 |
印斯拜尔药品股份有限公司 |
用吲哚衍生物降低眼内压的方法
|
WO2002016353A1
(en)
|
2000-08-17 |
2002-02-28 |
Celltech R & D Limited |
Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatory disorders
|
ATE402699T1
(de)
|
2000-09-06 |
2008-08-15 |
Ortho Mcneil Pharm Inc |
Verwendung von substituierten pyrazolen zur behandlung von allergien
|
HN2001000224A
(es)
|
2000-10-19 |
2002-06-13 |
Pfizer |
Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos.
|
US20070004713A1
(en)
|
2000-12-07 |
2007-01-04 |
Bernard Barlaam |
Therapeutic benimidazole compounds
|
US6849643B2
(en)
|
2000-12-08 |
2005-02-01 |
Ortho-Mcneil Pharmaceutical, Inc. |
Indazolyl-substituted pyrroline compounds as kinase inhibitors
|
US20030109714A1
(en)
|
2001-03-22 |
2003-06-12 |
Neil Wishart |
Transition metal mediated process
|
US20030009034A1
(en)
|
2001-03-22 |
2003-01-09 |
Neil Wishart |
Transition metal mediated process
|
GB0115393D0
(en)
|
2001-06-23 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
DE10135050A1
(de)
|
2001-07-09 |
2003-02-06 |
Schering Ag |
1-Ary1-2-N-, S- oder O-substituierte Benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate
|
WO2003020276A1
(en)
|
2001-08-30 |
2003-03-13 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
WO2003024899A2
(en)
|
2001-09-17 |
2003-03-27 |
Bristol-Myers Squibb Company |
CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
|
WO2003040114A1
(en)
|
2001-11-06 |
2003-05-15 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
US7632955B2
(en)
|
2001-12-13 |
2009-12-15 |
National Health Research Institutes |
Indole compounds
|
US7528165B2
(en)
|
2001-12-13 |
2009-05-05 |
National Health Research Institutes |
Indole compounds
|
US7244847B2
(en)
|
2002-02-06 |
2007-07-17 |
Isis Pharmaceuticals, Inc. |
Benzimidazole compounds
|
DE10207843A1
(de)
|
2002-02-15 |
2003-09-04 |
Schering Ag |
Mikrolia-Inhibitoren zur Unterbrechung von Interleukin 12 und IFN-gamma vermittelten Immunreaktionen
|
GB0206860D0
(en)
|
2002-03-22 |
2002-05-01 |
Glaxo Group Ltd |
Compounds
|
MXPA04009243A
(es)
|
2002-04-12 |
2005-06-08 |
Pfizer |
Uso de ligandos para el receptor ep4 en el tratamiento de enfermedades vinculadas a il-6.
|
DE60319364T2
(de)
|
2002-05-08 |
2009-02-19 |
Janssen Pharmaceutica N.V. |
Substituierte pyrroline als kinase inhibitoren
|
US6951881B2
(en)
|
2002-05-10 |
2005-10-04 |
Wyeth |
(1-substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
|
ES2312785T3
(es)
|
2002-06-05 |
2009-03-01 |
Janssen Pharmaceutica Nv |
Pirrolinas sustituidas utiles como inhibidores de quinasa.
|
US20050282733A1
(en)
|
2002-06-27 |
2005-12-22 |
Prins Johannes B |
Differentiation modulating agents and uses therefor
|
EP1388541A1
(en)
*
|
2002-08-09 |
2004-02-11 |
Centre National De La Recherche Scientifique (Cnrs) |
Pyrrolopyrazines as kinase inhibitors
|
AU2003300791A1
(en)
|
2002-12-13 |
2004-07-09 |
Neurogen Corporation |
Combination therapy for the treatment of pain
|
US7189716B2
(en)
|
2003-01-03 |
2007-03-13 |
Bristol-Myers Squibb Company |
Tyrosine kinase inhibitors
|
EP1606266A4
(en)
|
2003-03-21 |
2008-06-25 |
Smithkline Beecham Corp |
CHEMICAL COMPOUNDS
|
US20060035945A1
(en)
|
2003-05-30 |
2006-02-16 |
Giorgio Attardo |
Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
|
CA2530081A1
(en)
*
|
2003-07-01 |
2005-01-13 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
US7312215B2
(en)
|
2003-07-29 |
2007-12-25 |
Bristol-Myers Squibb Company |
Benzimidazole C-2 heterocycles as kinase inhibitors
|
ES2228268B1
(es)
|
2003-07-30 |
2006-07-01 |
Laboratorios Del Dr. Esteve, S.A. |
Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
|
ES2228267B1
(es)
|
2003-07-30 |
2006-07-01 |
Laboratorios Del Dr. Esteve, S.A. |
Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
|
ES2222832B1
(es)
|
2003-07-30 |
2006-02-16 |
Laboratorios Del Dr. Esteve, S.A. |
Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos.
|
AU2004272004B2
(en)
|
2003-09-10 |
2009-01-22 |
Merck Sharp & Dohme Corp. |
17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
|
MXPA06002853A
(es)
|
2003-09-11 |
2006-06-14 |
Kemia Inc |
Inhibidores citoquina.
|
US20050164300A1
(en)
|
2003-09-15 |
2005-07-28 |
Plexxikon, Inc. |
Molecular scaffolds for kinase ligand development
|
WO2005041951A2
(en)
|
2003-10-28 |
2005-05-12 |
Rigel Pharmaceuticals, Inc. |
Rhodanine derivatives for use as antiviral agents
|
EP1532980A1
(en)
|
2003-11-24 |
2005-05-25 |
Novo Nordisk A/S |
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
|
EP1690538A4
(en)
|
2003-12-02 |
2009-02-25 |
Shionogi & Co |
ISOXAZOLE DERIVATIVE AGONISTIC ACTION AGAINST PEROXISOM PROLIFERATOR ACTIVATED RECEPTOR
|
US7791047B2
(en)
|
2003-12-12 |
2010-09-07 |
Semequip, Inc. |
Method and apparatus for extracting ions from an ion source for use in ion implantation
|
WO2005065686A1
(en)
|
2004-01-07 |
2005-07-21 |
Adipogen Pharmaceuticals Pty Limited |
Differentiation modulating agents and uses therefor
|
JPWO2005108370A1
(ja)
|
2004-04-16 |
2008-03-21 |
味の素株式会社 |
ベンゼン化合物
|
US20050250829A1
(en)
|
2004-04-23 |
2005-11-10 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
EP1751124A4
(en)
|
2004-05-07 |
2010-04-14 |
Exelixis Inc |
RAF MODULATORS AND METHODS OF USE
|
WO2005118580A2
(en)
|
2004-05-12 |
2005-12-15 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health |
Tricyclic compounds as inhibitors of the hypoxic signaling pathway
|
EP1776106B1
(en)
|
2004-06-22 |
2013-08-07 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives for modulation of calcium channels
|
MX2007000481A
(es)
|
2004-07-14 |
2007-03-29 |
Ptc Therapeutics Inc |
Metodos para tratar hepatitis c.
|
US7868037B2
(en)
|
2004-07-14 |
2011-01-11 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
US7781478B2
(en)
|
2004-07-14 |
2010-08-24 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
ES2246721B1
(es)
|
2004-08-10 |
2007-03-16 |
Laboratorios Del Dr. Esteve, S.A. |
Compuestos indolicos sustituidos, su preparacion y su uso como medicamentos.
|
EP1632491A1
(en)
|
2004-08-30 |
2006-03-08 |
Laboratorios Del Dr. Esteve, S.A. |
Substituted indole compounds and their use as 5-HT6 receptor modulators
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
WO2006043145A1
(en)
|
2004-10-21 |
2006-04-27 |
Pfizer Inc. |
Inhibitors of hepatitis c virus protease, and compositions and treatments using the same
|
MX2007005159A
(es)
|
2004-10-29 |
2007-06-26 |
Tibotec Pharm Ltd |
Derivados de pirimidina biciclicos inhibidores del vih.
|
WO2006060737A2
(en)
|
2004-12-03 |
2006-06-08 |
Takeda San Diego, Inc. |
Mitotic kinesin inhibitors
|
WO2007106436A2
(en)
|
2006-03-10 |
2007-09-20 |
Mallinckrodt Inc. |
Photoactive compounds and compositions and uses thereof
|
US7576222B2
(en)
|
2004-12-28 |
2009-08-18 |
Wyeth |
Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase
|
US20060156486A1
(en)
|
2005-01-14 |
2006-07-20 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
GB0501999D0
(en)
|
2005-02-01 |
2005-03-09 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
EP1853255A4
(en)
|
2005-02-22 |
2009-07-08 |
Gemin X Pharmaceuticals Canada |
METHODS FOR TREATING ARTHRITIS USING TRIHETEROCYCLIC COMPOUNDS
|
EP1702915A1
(en)
|
2005-03-14 |
2006-09-20 |
Cephalon France |
Process for enantioselective synthesis of single enantiomers of thio-substituted arylmethanesulfinyl derivatives by asymmetric oxidation
|
DE102005012873B4
(de)
|
2005-03-19 |
2007-05-03 |
Sanofi-Aventis Deutschland Gmbh |
Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102005012872A1
(de)
|
2005-03-19 |
2006-09-28 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte, bizyklische 8-Pyrrolidino-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE102005012875B4
(de)
|
2005-03-19 |
2006-11-16 |
Sanofi-Aventis Deutschland Gmbh |
Verwendung von Amino substituierten 8-N-Benzimidazolen
|
US20060229355A1
(en)
|
2005-04-08 |
2006-10-12 |
The Regents Of The University Of California |
3.3'-Diindolylmethane compositions inhibit angiogenesis
|
WO2006117314A2
(en)
|
2005-04-30 |
2006-11-09 |
Boehringer Ingelheim International Gmbh |
Novel piperidin- substituted indoles and their use as ccr-3 modulators
|
JP2007056213A
(ja)
|
2005-08-26 |
2007-03-08 |
Fujifilm Corp |
焼結含油軸受油用組成物、並びにそれを用いた軸受け装置及び摺動部材
|
US20100190768A1
(en)
|
2005-09-30 |
2010-07-29 |
Dainippon Sumitomo Pharma Co., Ltd. |
Novel fused pyrole derivative
|
WO2007042321A2
(en)
|
2005-10-13 |
2007-04-19 |
Devgen N.V. |
Kinase inhibitors
|
MX2008005666A
(es)
|
2005-11-03 |
2009-03-02 |
Ilypsa Inc |
Compuestos multivalentes de indol y uso de los mismos como inhibidores de fosfolipasa-a2.
|
EP1951315A2
(en)
|
2005-11-03 |
2008-08-06 |
Ilypsa, Inc. |
Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors
|
CN101426777A
(zh)
|
2005-12-21 |
2009-05-06 |
先灵公司 |
用作组胺h3拮抗剂的苯氧基哌啶及其类似物
|
MX2008009022A
(es)
|
2006-01-13 |
2008-09-24 |
Wyeth Corp |
1h-indoles sustituidos por sulfonilo como ligandos para los receptores 5-hidroxitriptamina.
|
WO2007084435A2
(en)
|
2006-01-13 |
2007-07-26 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis c
|
EP1986633B1
(en)
|
2006-02-10 |
2014-07-30 |
Summit Corporation Plc |
Treatment of duchenne muscular dystrophy
|
CN101394829A
(zh)
|
2006-03-07 |
2009-03-25 |
宝洁公司 |
用于氧化性染色角蛋白纤维的组合物和使用此类组合物的方法
|
EP2952185A1
(en)
|
2006-03-20 |
2015-12-09 |
Spinifex Pharmaceuticals Pty Ltd |
Method of treatment or prophylaxis of inflammatory pain
|
CA2869945C
(en)
|
2006-04-07 |
2018-01-23 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
US20080027044A1
(en)
|
2006-06-13 |
2008-01-31 |
Kim Lewis |
Prodrug antibiotic screens
|
CA2658959A1
(en)
|
2006-06-23 |
2007-12-27 |
Laboratorios Del Dr. Esteve, S.A. |
Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity
|
CA2563116A1
(en)
|
2006-07-06 |
2008-01-06 |
Gemin X Biotechnologies Inc. |
Methods for treating or preventing anemia or thrombocytopenia using a triheterocyclic compound
|
EP1878724A1
(en)
|
2006-07-15 |
2008-01-16 |
sanofi-aventis |
A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles
|
EP1902733A1
(en)
|
2006-09-19 |
2008-03-26 |
Laboratorios Del Dr. Esteve, S.A. |
Combination of a NMDA-receptor ligand and a compound with 5-HT6 receptor affinity
|
ES2627352T3
(es)
*
|
2006-10-19 |
2017-07-27 |
Signal Pharmaceuticals, Llc |
Compuestos heteroarilo, sus composiciones y su uso como inhibidores de proteínas quinasas
|
TW200827340A
(en)
*
|
2006-11-10 |
2008-07-01 |
Astrazeneca Ab |
Chemical compounds
|
US8383662B2
(en)
|
2006-12-05 |
2013-02-26 |
National Chiao Tung University |
Bicyclic heteroaryl compounds
|
WO2008070599A1
(en)
|
2006-12-05 |
2008-06-12 |
Chung-Ming Sun |
Indazole compounds
|
US20080161254A1
(en)
|
2007-01-03 |
2008-07-03 |
Virobay, Inc. |
Hcv inhibitors
|
KR20090111847A
(ko)
|
2007-01-19 |
2009-10-27 |
아디아 바이오사이언스즈 인크. |
Mek 억제제
|
CN101016294A
(zh)
|
2007-03-13 |
2007-08-15 |
中国人民武装警察部队医学院 |
具有多种生物活性的取代吲哚-3-基草酰胺衍生物
|
JP2010138072A
(ja)
|
2007-03-29 |
2010-06-24 |
Dainippon Sumitomo Pharma Co Ltd |
新規な縮合ピロール誘導体
|
EP2173721B1
(en)
|
2007-06-26 |
2011-12-28 |
Sanofi |
A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
|
CN101085779A
(zh)
|
2007-07-11 |
2007-12-12 |
中国人民武装警察部队医学院 |
取代吲哚-3-基草酰表鬼臼毒素衍生物及其盐及其用途
|
EP2018861A1
(en)
|
2007-07-26 |
2009-01-28 |
Laboratorios del Dr. Esteve S.A. |
5HT6-Ligands such as sulfonamide derivatives in drug-induced weight-gain
|
DE602007012080D1
(de)
|
2007-08-01 |
2011-03-03 |
Esteve Labor Dr |
Kombination von mindestens zwei 5-HT6-Liganden
|
JP2010535708A
(ja)
|
2007-08-03 |
2010-11-25 |
ビオマリン アイジーエー リミテッド |
デュシェンヌ型筋ジストロフィーの治療のための薬物併用
|
MX2010001650A
(es)
|
2007-08-10 |
2010-08-02 |
Glaxosmithkline Llc |
Entidades quimicas biciclicas que contienen nitrogeno para el tratamiento de infecciones virales.
|
AU2008293532B2
(en)
|
2007-08-27 |
2014-08-28 |
Kineta Four Llc |
Antiviral drugs for treatment of Arenavirus infection
|
US9101628B2
(en)
|
2007-09-18 |
2015-08-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and composition of treating a flaviviridae family viral infection
|
CN101903026B
(zh)
|
2007-09-18 |
2013-05-08 |
斯坦福大学 |
抑制剂在制备用于治疗黄病毒家族病毒感染的药物中的用途
|
DE102007048447A1
(de)
|
2007-10-10 |
2009-04-16 |
Bayer Healthcare Ag |
Substituierte Dihydropyrazolthione und ihre Verwendung
|
DE102007049157A1
(de)
|
2007-10-13 |
2009-04-16 |
Bayer Healthcare Ag |
Substituierte Dihydrotriazolone und ihre Verwendung
|
KR20100113500A
(ko)
|
2008-01-15 |
2010-10-21 |
시가 테크놀로지스, 인크. |
아레나바이러스 감염 치료용 항바이러스 약물
|
US7947723B2
(en)
|
2008-02-01 |
2011-05-24 |
Spelman College |
Synthesis and anti-proliferative effect of benzimidazole derivatives
|
CN102046179B
(zh)
|
2008-04-09 |
2015-01-14 |
英菲尼提制药公司 |
脂肪酸酰胺水解酶抑制剂
|
EA201001687A1
(ru)
*
|
2008-04-29 |
2011-06-30 |
Новартис Аг |
Производные имидазопиридина в качестве ингибиторов активиноподобной рецепторной киназы ( alk-4 или alk-5 )
|
WO2009134850A1
(en)
|
2008-04-30 |
2009-11-05 |
Smithkline Beecham Corporation |
Prolyl hydroxylase inhibitors
|
US20090311217A1
(en)
|
2008-05-28 |
2009-12-17 |
Wyeth |
3-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
|
CA2763536C
(en)
|
2008-05-30 |
2017-05-09 |
Marvin J. Miller |
Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria
|
BRPI0915231A2
(pt)
|
2008-07-08 |
2018-06-12 |
Intellikine Inc |
compostos inibidores de quinase e métodos de uso
|
US20100061982A1
(en)
|
2008-09-10 |
2010-03-11 |
Wyeth |
3-substituted-1h-indole, 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
|
WO2010030360A1
(en)
|
2008-09-11 |
2010-03-18 |
Arena Pharmaceuticals, Inc. |
3H-IMIDAZO[4,5-b]PYRIDIN-5-OL DERIVATIVES USEFUL IN THE TREATMENT OF GPR81 RECEPTOR DISORDERS
|
GB0817576D0
(en)
|
2008-09-25 |
2008-11-05 |
Lectus Therapeutics Ltd |
Calcium ion channel modulators & uses thereof
|
CN101723936B
(zh)
|
2008-10-27 |
2014-01-15 |
上海睿星基因技术有限公司 |
激酶抑制剂及其在药学中的用途
|
EP2358202B1
(en)
|
2008-11-03 |
2016-06-15 |
Merck Sharp & Dohme Corp. |
Benzimidazole and aza-benzimidazole carboxamides
|
US20110237633A1
(en)
|
2008-12-11 |
2011-09-29 |
Bijoy Panicker |
Small molecule modulators of hepatocyte growth factor (scatter factor) activity
|
TWI519530B
(zh)
|
2009-02-20 |
2016-02-01 |
艾伯維德國有限及兩合公司 |
羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途
|
CN102448458B
(zh)
|
2009-03-18 |
2015-07-22 |
小利兰·斯坦福大学理事会 |
治疗黄病毒科病毒感染的方法和组合物
|
US20190127365A1
(en)
|
2017-11-01 |
2019-05-02 |
Merck Sharp & Dohme Corp. |
Inhibitors of hepatitis c virus replication
|
RU2011144819A
(ru)
|
2009-04-06 |
2013-05-20 |
ПиТиСи ТЕРАПЬЮТИКС, ИНК |
Соединения и способы противовирусного лечения
|
WO2010117935A1
(en)
|
2009-04-06 |
2010-10-14 |
Schering Corporation |
Compounds and methods for antiviral treatment
|
WO2010118009A1
(en)
|
2009-04-06 |
2010-10-14 |
Ptc Therapeutics, Inc. |
Hcv inhibitor and therapeutic agent combinations
|
ES2465971T3
(es)
|
2009-04-06 |
2014-06-09 |
University Health Network |
Inhibidores de quinasa y método para tratar cáncer con los mismos
|
US8841302B2
(en)
|
2009-04-06 |
2014-09-23 |
Ptc Therapeutics, Inc. |
HCV inhibitor and therapeutic agent combinations
|
US9198907B2
(en)
|
2009-04-06 |
2015-12-01 |
Ptc Therapeutics, Inc. |
Combinations of a HCV inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent
|
BRPI1014174B8
(pt)
|
2009-04-22 |
2021-05-25 |
Askat Inc |
uso de um composto selecionado a partir de 4-((1s)-1-{[5-cloro-2-(4-fluorofenóxi)benzoil]amino}etil)ácido benzóico, 4-[(1s)-1-({[5-cloro-2-(3-fluorofenóxi)piridin-3-il]carbonil}amino)etil]ácido benzóico e 3-[2-(4-{2-etil-4,6-dimetil-1h-imidazo[4,5-c]piridin-1-il}fenil)etil]-1-[(4-metilbenzeno)sulfonil]urea para tratamento de um câncer epitelial relacionado à pge2
|
US8492374B2
(en)
|
2009-04-29 |
2013-07-23 |
Industrial Technology Research Institute |
Azaazulene compounds
|
WO2010132684A2
(en)
|
2009-05-13 |
2010-11-18 |
University Of Virginia Patent Foundation |
Inhibitors of inv(16) leukemia
|
GB0910003D0
(en)
|
2009-06-11 |
2009-07-22 |
Univ Leuven Kath |
Novel compounds for the treatment of neurodegenerative diseases
|
AP2012006094A0
(en)
|
2009-06-30 |
2012-02-29 |
Siga Technologies Inc |
Treatment and prevention of dengue virus infections.
|
WO2011002520A2
(en)
|
2009-07-02 |
2011-01-06 |
Angion Biomedica Corp. |
Small molecule inhibitors of parp activity
|
EP2464227A4
(en)
|
2009-08-10 |
2013-02-20 |
Galenea Corp |
COMPOUNDS AND METHODS OF USE
|
US9340555B2
(en)
|
2009-09-03 |
2016-05-17 |
Allergan, Inc. |
Compounds as tyrosine kinase modulators
|
WO2011028995A1
(en)
|
2009-09-03 |
2011-03-10 |
Allergan, Inc. |
Compounds as tyrosine kinase modulators
|
TWI504600B
(zh)
|
2009-12-18 |
2015-10-21 |
Mitsubishi Tanabe Pharma Corp |
新穎抗血小板藥
|
EP2519522B1
(en)
|
2009-12-30 |
2014-09-24 |
ArQule, Inc. |
Substituted imidazopyridinyl-aminopyridine compounds
|
BR112012020236A2
(pt)
|
2010-02-22 |
2016-05-17 |
Raqualia Pharma Inc |
uso de um composto com atividade antagonística de ep4 ou um sal farmaceuticamente aceitável do mesmo, uso de um composto da fórmula (i), (ii), (iii), (iv), (va) ou (vb), ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica e método para o tratamento de doenças mediadas por il-23 em um sujeito animal, incluindo um sujeito mamífero
|
WO2011116176A1
(en)
|
2010-03-17 |
2011-09-22 |
Sirtris Pharmaceuticals Inc. |
3-substitued imidazo (4, 5-b) pyridines and analogs as sirtuin modulators
|
EP2552207B1
(en)
|
2010-04-02 |
2019-08-21 |
Firmenich Incorporated |
Sweet flavor modifier
|
CN102219725B
(zh)
|
2010-04-16 |
2013-10-09 |
中国科学院上海药物研究所 |
苯并杂环类化合物及其制备方法和用途
|
EP2571878B1
(en)
|
2010-05-17 |
2018-10-17 |
Incozen Therapeutics Pvt. Ltd. |
Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b]pyridine compounds as modulators of protein kinases
|
US8835445B2
(en)
|
2010-06-02 |
2014-09-16 |
Trius Therapeutics, Inc. |
Dihydrofolate reductase inhibitors
|
US20130165426A1
(en)
*
|
2010-07-06 |
2013-06-27 |
Université de Montréal |
Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators
|
WO2012009258A2
(en)
|
2010-07-13 |
2012-01-19 |
Edward Roberts |
Peptidomimetic galanin receptor modulators
|
WO2012044567A2
(en)
|
2010-09-30 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Imidazole derivatives
|
US10005750B2
(en)
|
2010-10-06 |
2018-06-26 |
J-Pharma Co., Ltd. |
Developing potent urate transporter inhibitors: compounds designed for their uricosuric action
|
WO2012065065A1
(en)
|
2010-11-12 |
2012-05-18 |
Follica, Inc. |
Methods and compositions for modulating hair growth, wound healing and scar revision
|
GB201021103D0
(en)
|
2010-12-13 |
2011-01-26 |
Univ Leuven Kath |
New compounds for the treatment of neurodegenerative diseases
|
GB201021104D0
(en)
|
2010-12-13 |
2011-01-26 |
Univ Leuven Kath |
Novel compounds for the treatment of neurodegenerative diseases
|
JP5990106B2
(ja)
|
2011-01-28 |
2016-09-07 |
佐藤製薬株式会社 |
縮環化合物
|
USRE47009E1
(en)
|
2011-02-01 |
2018-08-28 |
The Children's Hospital Of Philadelphia |
HDAC inhibitors and therapeutic methods using the same
|
EP2673269A1
(en)
|
2011-02-09 |
2013-12-18 |
F.Hoffmann-La Roche Ag |
Heterocyclic compounds as pi3 kinase inhibitors
|
EP2678342B1
(en)
|
2011-02-25 |
2015-01-07 |
Takeda Pharmaceutical Company Limited |
N-substituted oxazinopteridines and oxazinopteridinones
|
CA2829558A1
(en)
|
2011-03-09 |
2012-09-13 |
Celgene Avilomics Research, Inc. |
Pi3 kinase inhibitors and uses thereof
|
MX342882B
(es)
|
2011-03-16 |
2016-10-14 |
Mitsubishi Tanabe Pharma Corp |
Compuestos de sulfonamida que tienen actividad antagonista de canales de potencial de receptor transitorio melastatina 8.
|
US20140303163A1
(en)
|
2011-03-24 |
2014-10-09 |
Ying Luo |
Use of kinase inhibitors in preventing and treating inflammatory disorder
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
EP2518071A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Imidazopyridine derivatives as PI3K inhibitors
|
US20130072473A1
(en)
|
2011-05-09 |
2013-03-21 |
Proteostasis Therapeutics, Inc. |
Compounds for treating protein folding disorders
|
JP5959330B2
(ja)
|
2011-06-17 |
2016-08-02 |
田辺三菱製薬株式会社 |
新規抗血小板薬
|
JP2014528446A
(ja)
|
2011-10-06 |
2014-10-27 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
1,3−置換アゼチジンpde10阻害剤
|
US8946445B2
(en)
|
2011-10-12 |
2015-02-03 |
Nanjing Allgen Pharma Co., Ltd. |
Heterocyclic molecules as apoptosis inducers
|
WO2013078254A1
(en)
|
2011-11-22 |
2013-05-30 |
Array Biopharma Inc. |
Bicyclic heteroaryl derivatives as kinase inhibitors
|
US8785459B2
(en)
|
2011-12-27 |
2014-07-22 |
Development Center For Biotechnology |
Quinazoline compounds as kinase inhibitors
|
US20150119402A1
(en)
|
2012-05-08 |
2015-04-30 |
The Regents Of The University Of California |
Alpha 7 nicotinic acetylcholine allosteric modulators, their derivatives and uses thereof
|
EP2858983B1
(en)
|
2012-06-11 |
2018-04-18 |
UCB Biopharma SPRL |
Tnf-alpha modulating benzimidazoles
|
DK2882440T3
(da)
|
2012-08-07 |
2019-05-06 |
Novartis Ag |
Farmaceutiske kombinationer, der omfatter en b-raf-inhibitor, en egfr-inhibitor og eventuelt en pi3k-alfa-inhibitor
|
WO2014047427A2
(en)
|
2012-09-21 |
2014-03-27 |
Vanderbilt University |
Substituted benzofuran, benzothiophene and indole mcl-1 inhibitors
|
MX2015003653A
(es)
|
2012-09-21 |
2015-09-25 |
Sanofi Sa |
Derivados de amida del acido benzoimidazol-carboxilico como moduladores del receptor apj.
|
GB201217285D0
(en)
|
2012-09-27 |
2012-11-14 |
Univ Central Lancashire |
Indole derivatives
|
AU2013344464A1
(en)
|
2012-11-16 |
2015-05-21 |
The Regents Of The University Of California |
Pictet-Spengler ligation for protein chemical modification
|
CA2906008C
(en)
|
2013-03-13 |
2019-07-09 |
Flatley Discovery Lab, Llc |
Pyridazinone compounds and methods for the treatment of cystic fibrosis
|
EP2970266B1
(en)
|
2013-03-15 |
2018-01-31 |
Epizyme, Inc. |
1-phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
|
KR102556734B1
(ko)
|
2013-03-19 |
2023-07-18 |
에스크엣 인크. |
연골질환 치료에서의 ep4 수용체 길항제의 용도
|
WO2014179785A1
(en)
|
2013-05-03 |
2014-11-06 |
Inscent, Inc. |
Improved honeybee repellents and uses thereof
|
EP3004088A1
(en)
|
2013-05-24 |
2016-04-13 |
Iomet Pharma Ltd. |
Slc2a transporter inhibitors
|
US10939682B2
(en)
*
|
2013-07-02 |
2021-03-09 |
Syngenta Participations Ag |
Pesticidally active bi- or tricyclic heterocycles with sulfur containing substituents
|
LT3049417T
(lt)
|
2013-07-31 |
2019-02-11 |
Merck Patent Gmbh |
Piridinai, pirimidnai ir pirazinai kaip btk inhibitoriai ir jų panaudojimas
|
CA2922341C
(en)
|
2013-08-28 |
2022-06-07 |
Vanderbilt University |
Substituted indole mcl-1 inhibitors
|
CN104418849B
(zh)
|
2013-09-02 |
2020-04-21 |
广东东阳光药业有限公司 |
取代的氨基嘧啶类化合物及其使用方法和用途
|
WO2015073528A1
(en)
|
2013-11-12 |
2015-05-21 |
Proteostasis Therapeutics, Inc. |
Proteasome activity enhancing compounds
|
GB201321739D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
GB201321741D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
EP3116506B1
(en)
|
2014-03-13 |
2019-04-17 |
Merck Sharp & Dohme Corp. |
2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
|
PT3143011T
(pt)
|
2014-05-13 |
2021-04-26 |
Hoffmann La Roche |
Compostos heterocíclicos deuterados e a sua utilização como agentes de imagiologia
|
CN105732464A
(zh)
|
2014-12-31 |
2016-07-06 |
杏国新药股份有限公司 |
一种规模化生产吲哚化合物的方法
|
US9809539B2
(en)
|
2015-03-03 |
2017-11-07 |
Shuttle Pharmaceuticals, Llc |
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
|
AR104259A1
(es)
|
2015-04-15 |
2017-07-05 |
Celgene Quanticel Res Inc |
Inhibidores de bromodominio
|
LT3288940T
(lt)
|
2015-04-29 |
2021-05-10 |
Janssen Pharmaceutica Nv |
Azabenzimidazolai ir jų panaudojimas kaip ampa receptoriaus moduliatorių
|
US11046692B2
(en)
|
2015-04-30 |
2021-06-29 |
Memorial Sloan-Kettering Cancer Center |
Mitragynine analogs and uses thereof
|
WO2016196890A1
(en)
|
2015-06-04 |
2016-12-08 |
Vtv Therapeutics Llc |
Inhibitors of hexokinase and methods of use thereof
|
WO2017025989A1
(en)
|
2015-08-11 |
2017-02-16 |
Connexios Life Sciences Pvt. Ltd. |
Method of wound healing
|
WO2017064068A1
(en)
*
|
2015-10-14 |
2017-04-20 |
Almirall, S.A. |
New trpa1 antagonists
|
CA3005809A1
(en)
|
2015-11-25 |
2017-06-01 |
Ucb Biopharma Sprl |
Iminotetrahydropyrimidinone derivatives as plasmepsin v inhibitors
|
GB201521059D0
(en)
|
2015-11-30 |
2016-01-13 |
Isis Innovation |
Inhibitors of metallo-beta-lactamases
|
GB201603104D0
(en)
|
2016-02-23 |
2016-04-06 |
Ucb Biopharma Sprl |
Therapeutic agents
|
KR102643972B1
(ko)
|
2016-03-30 |
2024-03-07 |
솔루스첨단소재 주식회사 |
유기 발광 화합물 및 이를 이용한 유기 전계 발광 소자
|
ES2886587T3
(es)
|
2016-04-15 |
2021-12-20 |
Cancer Research Tech Ltd |
Compuestos heterocíclicos como inhibidores de la quinasa RET
|
JP7113810B2
(ja)
|
2016-07-07 |
2022-08-05 |
ブリストル-マイヤーズ スクイブ カンパニー |
Rock阻害剤としてのスピロラクタム
|
US11191762B2
(en)
|
2016-11-16 |
2021-12-07 |
Amgen Inc. |
Alkyl substituted triazole compounds as agonists of the APJ Receptor
|
EP3541810B1
(en)
*
|
2016-11-16 |
2020-12-23 |
Amgen Inc. |
Triazole phenyl compounds as agonists of the apj receptor
|
EP3541792B1
(en)
|
2016-11-16 |
2020-12-23 |
Amgen Inc. |
Triazole furan compounds as agonists of the apj receptor
|
EP4257596A3
(en)
|
2016-12-22 |
2023-12-06 |
Illumina Cambridge Limited |
Coumarin compounds and their uses as fluorescent labels
|
JP2020506904A
(ja)
|
2017-01-27 |
2020-03-05 |
シグナルアールエックス ファーマシューティカルズ,インコーポレイテッド |
キナーゼ、ブロモドメイン及びチェックポイント阻害剤としてのチエノピラノン及びフラノピラノン
|
CN110662544A
(zh)
|
2017-03-24 |
2020-01-07 |
纳诺森公司 |
具有有用的药学应用的稠合***并嘧啶化合物
|
GB201708451D0
(en)
|
2017-05-26 |
2017-07-12 |
Univ Oxford Innovation Ltd |
Inhibitors of metallo-beta-lactamases
|
KR20200041294A
(ko)
|
2017-06-21 |
2020-04-21 |
샤이 테라퓨틱스 엘엘씨 |
암, 염증성 질환, 신경발달질환 및 섬유증 질환의 치료를 위하여 Ras 수퍼패밀리와 상호작용하는 화합물
|
US10072045B1
(en)
|
2017-06-26 |
2018-09-11 |
Ramapo Pharmaceuticals, Inc. |
Antibacterial lipopeptides and methods for their preparation and use
|
CN109232362B
(zh)
|
2017-07-10 |
2022-12-27 |
广东东阳光药业有限公司 |
芳杂环类衍生物及其在药物上的应用
|
EP3661505A4
(en)
|
2017-08-02 |
2021-04-28 |
Spinogenix, Inc. |
BENZOTHIAZOLE AND RELATED COMPOUNDS
|
WO2019032720A1
(en)
|
2017-08-09 |
2019-02-14 |
Sanford Burnham Prebys Medical Discovery Institute |
APELIN RECEPTOR AGONISTS AND METHODS OF USE
|
IL273432B
(en)
|
2017-09-22 |
2022-09-01 |
Kymera Therapeutics Inc |
Protein compounds and their uses
|
WO2019060693A1
(en)
|
2017-09-22 |
2019-03-28 |
Kymera Therapeutics, Inc. |
CRBN LIGANDS AND USES THEREOF
|
EP3694504A4
(en)
|
2017-10-11 |
2021-07-14 |
ChemoCentryx, Inc. |
TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH CRC2 ANTAGONISTS
|
KR20190043437A
(ko)
|
2017-10-18 |
2019-04-26 |
씨제이헬스케어 주식회사 |
단백질 키나제 억제제로서의 헤테로고리 화합물
|
WO2019113523A1
(en)
|
2017-12-08 |
2019-06-13 |
Ashok Bajji |
Compounds and therapeutic uses thereof
|
US11572370B2
(en)
|
2018-01-08 |
2023-02-07 |
Biohaven Therapeutics Ltd. |
CD16A binding agents and uses thereof
|
CN112055713A
(zh)
|
2018-03-01 |
2020-12-08 |
安娜普尔纳生物股份有限公司 |
用于治疗与apj受体活性有关的疾病的化合物和组合物
|
US20210130312A1
(en)
|
2018-04-03 |
2021-05-06 |
Children's Hospital Medical Center |
Inhibitors of eya3-protein tyrosine phosphatase in dna damage repair signaling of pulmonary arterial hypertension
|
US11690824B2
(en)
|
2018-04-10 |
2023-07-04 |
The General Hospital Corporation |
Antibacterial compounds
|
US11299473B2
(en)
|
2018-04-13 |
2022-04-12 |
Incyte Corporation |
Benzimidazole and indole compounds and uses thereof
|
CN112292128A
(zh)
|
2018-04-16 |
2021-01-29 |
阿瑞斯医疗有限公司 |
Ep4抑制剂和其用途
|
AU2019271129B2
(en)
|
2018-05-14 |
2023-03-09 |
Nuvation Bio Inc. |
Anti-cancer nuclear hormone receptor-targeting compounds
|
EP3814338A1
(en)
|
2018-06-27 |
2021-05-05 |
Proteostasis Therapeutics, Inc. |
Proteasome activity enhancing compounds
|
CN110835333B
(zh)
|
2018-08-16 |
2022-10-18 |
中国药科大学 |
苯并咪唑取代唑类化合物及其用途
|
CA3110576A1
(en)
|
2018-09-18 |
2020-03-26 |
Terns, Inc. |
Compounds for treating certain leukemias
|
JP7515467B2
(ja)
|
2018-09-28 |
2024-07-12 |
アキュセラ インコーポレイテッド |
Vap-1の阻害剤
|
JP2022508648A
(ja)
|
2018-10-05 |
2022-01-19 |
アンナプルナ バイオ インコーポレイテッド |
Apj受容体活性に関連する状態を処置するための化合物および組成物
|
CA3126224A1
(en)
|
2019-01-08 |
2020-07-16 |
Phasebio Pharmaceuticals, Inc. |
Metalloenzyme inhibitor compounds
|
WO2020160225A1
(en)
|
2019-01-30 |
2020-08-06 |
Ohio State Innovation Foundation |
ESTROGEN RECEPTOR BETA (ERβ) AGONISTS FOR THE TREATMENT OF FIBROTIC CONDITIONS
|
CA3131620A1
(en)
|
2019-03-05 |
2020-09-10 |
F-star Therapeutics, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
WO2020201773A1
(en)
|
2019-04-05 |
2020-10-08 |
Storm Therapeutics Ltd |
Mettl3 inhibitory compounds
|
WO2020243457A1
(en)
|
2019-05-29 |
2020-12-03 |
Viogen Biosciences, Llc |
Compounds and therapeutic uses thereof
|
US11136318B2
(en)
|
2019-06-21 |
2021-10-05 |
Noramco, Llc |
Processes for the preparation of aryl hydrocarbon receptor ligands
|
CR20220178A
(es)
|
2019-10-25 |
2022-06-15 |
Gilead Sciences Inc |
Compuestos moduladores de glp-1r
|
WO2021096314A1
(ko)
|
2019-11-15 |
2021-05-20 |
가천대학교 산학협력단 |
신규한 벤즈이미다졸 유도체 및 이의 용도
|
US20210300912A1
(en)
|
2019-12-20 |
2021-09-30 |
Ikena Oncology, Inc. |
Aryl hydrocarbon receptor (ahr) agonists and uses thereof
|
WO2021154796A1
(en)
|
2020-01-29 |
2021-08-05 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
WO2021178362A1
(en)
|
2020-03-03 |
2021-09-10 |
VenatoRx Pharmaceuticals, Inc. |
Hepatitis b capsid assembly modulators
|
WO2021183760A1
(en)
|
2020-03-11 |
2021-09-16 |
Ohio State Innovation Foundation |
Methods of modulating t-cell activation using estrogen receptor beta (erβ) agonists
|